These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 32739275)
1. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis. Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
4. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H; Wang YT; Tsai JJ; Chen YC Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951 [TBL] [Abstract][Full Text] [Related]
5. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation. Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599 [TBL] [Abstract][Full Text] [Related]
6. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120 [TBL] [Abstract][Full Text] [Related]
7. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365 [TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524 [No Abstract] [Full Text] [Related]
9. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents. Agrawal R; Jain P; Dikshit SN Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189 [TBL] [Abstract][Full Text] [Related]
10. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study. Almasri IM; Taha MO; Mohammad MK Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649 [TBL] [Abstract][Full Text] [Related]
11. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis. Khalaf RA; Masalha D; Sabbah D Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469 [TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4. Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221 [TBL] [Abstract][Full Text] [Related]
13. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554. Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322 [TBL] [Abstract][Full Text] [Related]
14. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. Upadhyay J; Gajjar A; Suhagia BN Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759 [TBL] [Abstract][Full Text] [Related]
15. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4). Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062 [TBL] [Abstract][Full Text] [Related]
17. Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015 [TBL] [Abstract][Full Text] [Related]
18. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening. Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572 [TBL] [Abstract][Full Text] [Related]
19. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554. Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847 [TBL] [Abstract][Full Text] [Related]
20. An Update on Dipeptidyl Peptidase-IV Inhibiting Peptides. Sivaraman SA; Sabareesh V Curr Protein Pept Sci; 2024; 25(4):267-285. PubMed ID: 38173201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]